BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 20870902)

  • 1. Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease.
    Zhang Y; Sandy AR; Wang J; Radojcic V; Shan GT; Tran IT; Friedman A; Kato K; He S; Cui S; Hexner E; Frank DM; Emerson SG; Pear WS; Maillard I
    Blood; 2011 Jan; 117(1):299-308. PubMed ID: 20870902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells.
    Sandy AR; Chung J; Toubai T; Shan GT; Tran IT; Friedman A; Blackwell TS; Reddy P; King PD; Maillard I
    J Immunol; 2013 Jun; 190(11):5818-28. PubMed ID: 23636056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4
    Chung J; Radojcic V; Perkey E; Parnell TJ; Niknafs Y; Jin X; Friedman A; Labrecque N; Blazar BR; Brennan TV; Siebel CW; Maillard I
    J Immunol; 2019 Jul; 203(2):557-568. PubMed ID: 31182480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease.
    Zhao F; Zhang Y; Wang H; Jin M; He S; Shi Y; Guo Y; Zhang Y
    Blood; 2011 Feb; 117(5):1723-33. PubMed ID: 21119110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.
    Mochizuki K; Xie F; He S; Tong Q; Liu Y; Mochizuki I; Guo Y; Kato K; Yagita H; Mineishi S; Zhang Y
    J Immunol; 2013 Apr; 190(7):3772-82. PubMed ID: 23440416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
    Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
    Mochizuki K; Meng L; Mochizuki I; Tong Q; He S; Liu Y; Purushe J; Fung H; Zaidi MR; Zhang Y; Reshef R; Blazar BR; Yagita H; Mineishi S; Zhang Y
    Blood; 2016 Jun; 127(25):3270-80. PubMed ID: 27143255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
    Luo X; Xu L; Li Y; Tan H
    Cell Biol Toxicol; 2017 Apr; 33(2):169-181. PubMed ID: 27770236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
    Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
    Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migration and activation of T cells during development of graft-versus-host disease in a mouse model.
    Wen HS; Wang JM; Zhou H; Gong SI; Gao L; Wu Y
    Transplant Proc; 2013 Mar; 45(2):713-8. PubMed ID: 23498811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
    Lu SX; Kappel LW; Charbonneau-Allard AM; Atallah R; Holland AM; Turbide C; Hubbard VM; Rotolo JA; Smith M; Suh D; King C; Rao UK; Yim N; Bautista JL; Jenq RR; Penack O; Na IK; Liu C; Murphy G; Alpdogan O; Blumberg RS; Macian F; Holmes KV; Beauchemin N; van den Brink MR
    PLoS One; 2011; 6(7):e21611. PubMed ID: 21760897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of individual Notch ligands and receptors controls graft-versus-host disease.
    Tran IT; Sandy AR; Carulli AJ; Ebens C; Chung J; Shan GT; Radojcic V; Friedman A; Gridley T; Shelton A; Reddy P; Samuelson LC; Yan M; Siebel CW; Maillard I
    J Clin Invest; 2013 Apr; 123(4):1590-604. PubMed ID: 23454750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GCNT1-Mediated
    Perkey E; Maurice De Sousa D; Carrington L; Chung J; Dils A; Granadier D; Koch U; Radtke F; Ludewig B; Blazar BR; Siebel CW; Brennan TV; Nolz J; Labrecque N; Maillard I
    J Immunol; 2020 Mar; 204(6):1674-1688. PubMed ID: 32060138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
    Zhang Y; Hexner E; Frank D; Emerson SG
    J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH and Graft-Versus-Host Disease.
    Di Ianni M; Del Papa B; Baldoni S; Di Tommaso A; Fabi B; Rosati E; Natale A; Santarone S; Olioso P; Papalinetti G; Giancola R; Accorsi P; Di Bartolomeo P; Sportoletti P; Falzetti F
    Front Immunol; 2018; 9():1825. PubMed ID: 30147692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.
    Olson JA; Leveson-Gower DB; Gill S; Baker J; Beilhack A; Negrin RS
    Blood; 2010 May; 115(21):4293-301. PubMed ID: 20233969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.